has been acquired by
Selected Transactions
has been acquired by
has acquired
Aevi Genomic Medicine, Inc.
$15.6M plus contingent
value rights up to $6.5M
Aevi Genomic Medicine, Inc.
$15.6M plus contingent
value rights up to $6.5M
has acquired
has been acquired by 
Series Seed Preferred
Stock Financing
$5,000,000
has merged with
has acquired
Private Placement of
Subordinated Notes
Subordinated Notes
$12,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
has been acquired by
Thoroughbred Capital LLC
has acquired
Diabetic Health, Inc.
(f/k/a Clinical Sensors, Inc.)
Private Placement of
Fixed-to-Floating
Subordinated Notes
Due Dec 2029
$32,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
Series C Preferred Stock Financing
for NoHo Health, Inc.
US$25,000,000
Collaboration Agreement
with
Genective S.A.
Series B Investment
in eGenesis Bio
US$50,000,000
Pediatric Portfolio
has been acquired by
$43,000,000
has been acquired by
$43,000,000
Private Placement of
Subordinated Notes
Subordinated Notes
$10,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
has acquired
has been acquired by
Public Offering
of Common Stock
$14,000,000
$3,500,000
Class A Preferred Units
has been acquired by
Raptor Technologies, LLC
De Novo Formation and
Initial Public Offering
$22,500,000
Lead Book-Running Manager
in the $31,050,000 IPO for
$5,300,000
Public Offering
Series A Financing
$8,000,000
has been acquired by
Common Stock Offering
$10,000,000
Secondary Public Offering
$316,542,774
Private Placement of Mandatory
Convertible Subordinated Notes
Convertible Subordinated Notes
$18,550,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
Private Placement of
Common Stock and
Convertible Preferred Stock
Common Stock and
Convertible Preferred Stock
$15,200,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
has acquired
has acquired
Novum Pharmaceutical
Research Services
Follow-on Public Offering
of Common Stock
$3,400,000
$240,000,000
Rule 144A Offering of
1.25% Convertible Senior Notes
Due 2023
has been acquired by
has been acquired by
Waste Industries
has merged with
US$2.825 billion
US$2.825 billion
has merged with
has acquired
Follow-on Public Offering
of Common Stock
$63,250,008
Secondary Public Offering
$298,380,000
Waste Industries
has acquired the assets of
Lebanon Farms Disposal, Inc.
(Pennsylvania)
(Pennsylvania)
has merged with
Receivables Securitization
Financing
$250,000,000
Series A Financing
Up to $6 Million
has received a
growth equity investment from
Eli Lilly and Company
has acquired
AurKa Pharma, Inc.
$110,000,000 plus
up to $465,000,000
in regulatory and sales
milestones
Private Placement
of Common Stock
of Common Stock
$11,643,750
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
Waste Industries
has acquired
has acquired
a majority interest in
Follow-on Public Offering
of Common Stock
$19,968,000
has acquired the assets of
has acquired
has been acquired by
Series A Financing
$4,600,000
Common Stock
Rights Offering
Rights Offering
$12,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
has acquired
Private Placement
of Common Stock
of Common Stock
$30,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
Series A Financing
$4,500,000
has acquired
has acquired
certain assets from
has acquired
has merged with
Private Placement
of Common Stock
of Common Stock
$8,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
has been acquired by
Press Ganey Associates
has acquired
License and
Development Agreement
has acquired
has been acquired by
has merged with
has been acquired by
Shred-it USA, a subsidiary of
Stericycle (SRCL)
$19,500,000
Regulation A+ Offering
Waste Industries
has been acquired by
an investor group led by
HPS Investment Partners
HPS Investment Partners
Private Placement of
Common Stock and Non-voting
Convertible Preferred Stock
Common Stock and Non-voting
Convertible Preferred Stock
$17,500,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
previously sold. This announcement
appears as a matter of record only.
has acquired
Series B Financing
$10,000,000
has secured a
$30 million loan facility
from
$30 million loan facility
from
Knight Therapeutics Inc.